Procter & Gamble’s most recent trend suggests a bullish bias. One trading opportunity on Procter & Gamble is a Bull Put Spread using a strike $80.00 short put and a strike $75.00 long put offers a potential 10.13% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $80.00 by expiration. The full premium credit of $0.46 would be kept by the premium seller. The risk of $4.54 would be incurred if the stock dropped below the $75.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Procter & Gamble is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Procter & Gamble is bullish.
The RSI indicator is at 34.87 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Procter & Gamble
Former Fortune 500 execs join Colorado health-tech firm focused on thwarting opioid abuse
Sun, 18 Feb 2018 18:53:40 +0000
Greenwood Village-based Safe RX makes prescription drug bottles with combination locks designed to thwart opioid abuse. Former P&G brand manager Andy Cipra has been hired as chief commercial officer of Safe Rx, and former P&G executive Rick Meckstroth has been hired as vice president of business development. Adding Cipra and Meckstroth helps position Safe Rx to manage significant growth as the company rolls out what’s called locking prescription vial dispensing, which is designed to protect American communities and families from the risk of addiction, said Milton Cohen, CEO of Safe Rx.
Kimberly Clark Is Running Out of Room to Grow…What's Next?
Fri, 16 Feb 2018 23:11:00 +0000
Its products aren't selling as well as they used to, so the consumer products giant is shifting strategies in 2018.
Former P&G executives join leadership team of health tech firm
Fri, 16 Feb 2018 21:10:07 +0000
Two former Procter & Gamble Co. executives have joined the leadership team of Safe Rx, which makes prescription drug bottles with combination locks designed to thwart opioid abuse. Former P&G brand manager Andy Cipra has been hired as chief commercial officer of Safe Rx, and former P&G executive Rick Meckstroth has been hired as vice president of business development.
Can Billion-Dollar Startups Be Created From Big Companies’ Unused IP? Ex-Walgreens CEO Bets ‘Yes’
Fri, 16 Feb 2018 19:01:00 +0000
Can billion-dollar startups be created from big companies’ unused intellectual property? Ex-Walgreens CEO Greg Wasson bets “yes.”
5 Safe Dow Stocks for a Crazy Market
Fri, 16 Feb 2018 11:00:00 +0000
As markets take a tumble it’s worth considering stocks with a track record for being safe havens.
Also on Market Tamer…
Follow Us on Facebook